- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sanofi India Ltd (SANO)
Sanofi India Ltd stock price live, this page displays NSE SANO stock exchange data. View the SANO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sanofi India Ltd real time stock price chart below.
What Is the Sanofi India Ltd Stock Price Today?
The Sanofi India Ltd stock price today is 3,079.20.
What Is the Stock Symbol for Sanofi India Ltd?
The stock symbol for Sanofi India Ltd is "SANO."
What Stock Exchange Does Sanofi India Ltd Trade On?
Sanofi India Ltd is listed and trades on the NSE stock exchange.
Is Sanofi India Ltd a Good Stock to Buy?
Determining whether Sanofi India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SANO quote. (ISIN: INE058A01010)
What Is the Sanofi India Ltd Stock Price Today?
The Sanofi India Ltd stock price today is 3,079.20.
What Is the Stock Symbol for Sanofi India Ltd?
The stock symbol for Sanofi India Ltd is "SANO."
What Stock Exchange Does Sanofi India Ltd Trade On?
Sanofi India Ltd is listed and trades on the NSE stock exchange.
Is Sanofi India Ltd a Good Stock to Buy?
Determining whether Sanofi India Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SANO quote. (ISIN: INE058A01010)
3,079.20
-26.80(-0.86%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,069.30
3,105.40
52 wk Range
3,054.00
5,107.50
SANO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3,069.303,105.40
52 wk Range
3,054.005,107.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SANO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Pays a significant dividend to shareholders
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Sanofi India Ltd Earnings Call Summary for Q2/2026
- Sanofi India Q2 2026 EPS of 39.3 missed forecast of 44.4 by 11.49%; revenue of 4.43B fell short of 4.48B estimate; shares dropped 2.18%.
- Total income rose 7% in Q2 with domestic sales up 8%, but H1 income fell 4% and sales declined 2%, reflecting weak start to the year.
- Diabetes franchise drove growth with 14% Q2 increase and 17% H1 gain; management calls 2026 an 'acceleration year' for the diabetes unit.
- Partnership business grew only 2% in Q2; management expects recovery to market growth rates may not occur until 2027 amid transition challenges.
- Operating expenses fell 5% in Q2 and 15% in H1; PBT rose 19% to INR 112 crore; dividend payout expected to match or exceed prior year levels.
Last Updated: 2026-08-05, 07:26 a/m
Read Full TranscriptEarnings
Latest Release
Aug 04, 2026
EPS / Forecast
36.30 / 44.40
Revenue / Forecast
4.38B / 4.48B
Compare SANO to Peers and Sector
Metrics to compare | SANO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSANOPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.9x | 35.1x | −0.3x | |
PEG Ratio | −2.06 | 0.45 | 0.00 | |
Price/Book | 8.6x | 6.4x | 2.6x | |
Price / LTM Sales | 3.9x | 5.6x | 3.0x | |
Upside (Analyst Target) | 28.2% | 9.2% | 54.6% | |
Fair Value Upside | Unlock | 1.5% | 8.6% | Unlock |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sanofi India (SANO) Stock Price Today?
The Sanofi India stock price today is 3,079.20 INR.
What Stock Exchange Does Sanofi India Trade On?
Sanofi India is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Sanofi India?
The stock symbol for Sanofi India is "SANO."
Does Sanofi India Pay Dividends? What’s The Current Dividend Yield?
The Sanofi India dividend yield is 3.96%.
What Is the Sanofi India Market Cap?
As of today, Sanofi India market cap is 70.93B INR.
What Is Sanofi India's Earnings Per Share (TTM)?
The Sanofi India EPS (TTM) is 140.59.
When Is the Next Sanofi India Earnings Date?
Sanofi India will release its next earnings report on Oct 29, 2026.
From a Technical Analysis Perspective, Is SANO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sanofi India Stock Split?
Sanofi India has split 0 times.
How Many Employees Does Sanofi India Have?
Sanofi India has 1097 employees.
What is the current trading status of Sanofi India (SANO)?
As of Sep 12, 2026, Sanofi India (SANO) is trading at a price of 3,079.20 INR, with a previous close of 3,106.00 INR. The stock has fluctuated within a day range of 3,069.30 INR to 3,105.40 INR, while its 52-week range spans from 3,054.00 INR to 5,107.50 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.